| |
|
|
|
Applied DNA Sciences Inc.  
|
|
0.2764 -0.025 (-0.08%) |
09-20 16:00 |
|
Open: |
0.308 |
Pre close: |
0.3014 |
Target:
|
0.43
|
|
High: |
0.308 |
Low: |
0.27 |
Resistance:
|
0.37
0.44
|
|
Volume: |
655,846 |
Market Cap: |
9M |
Support:
|
0.25
0.21
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.35
 |
MACD |
MACD(12,26):
|
0.01 |
|
MA(20): |
0.32  |
Signal(12,26,9): |
0.00 |
|
MA(100): |
0.45 |
Stochastic Oscillator |
%K(14,3):
|
36.44 |
|
MA(250): |
0.67 |
%D(3): |
61.08 |
|
Average Volume(K) |
3-Month: |
47819
|
52-Week |
High:
|
1.84 |
|
10-Days: |
75366 |
Low: |
0.25 |
|
RSI |
RSI(14):
|
41.89 |
Change(%): |
-80.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.322 |
Return on Equity (ttm) |
-1713.0 |
Shares Out. (M) |
43.19 |
|
EPS Est. Current Year |
-0.440 |
Return on Assets (ttm) |
-139.8 |
Shares Float (M) |
32.56 |
|
EPS Est. Next Year |
-0.230 |
PEG Ratio |
0.00 |
% Held by Insiders |
23.39 |
|
EPS Est. Next Quarter |
-0.100 |
Qtrly Rev. Growth |
102.0 |
% Held by Institutions |
5.05 |
|
Forward EPS |
-0.140 |
Gross Profit (p.s.) |
0.063 |
Shares Short (K) |
1700 |
|
Book Value (p.s.) |
-0.050 |
EBITDA (p.s.) |
-0.238 |
P/E |
-0.86 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-5.53 |
|
Profit Margin |
-221.40 |
Operating Cash Flow
(M) |
-7.59 |
P/S |
85269400.00 |
|
Operating Margin |
-218.38 |
Levered Free Cash Flow
(M) |
-4.23 |
P/CF |
-1.57 |
|
|
|
|
|
|
